Point72 Asset Management, L.P. 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:00 am Sale |
2023-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Point72 Asset Management, L.P. | 2,552,822 3.200% |
-1,508,521 (-37.14%) |
Filing |
| 2023-10-18 4:15 pm Purchase |
2023-10-17 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Point72 Asset Management, L.P. | 4,061,343 5.100% |
4,061,343 (New Position) |
Filing |